Discovery of novel class of alpha selective PI3K inhibitors

被引:0
|
作者
Garland, Keira [1 ]
Hanan, Emily [1 ]
Staben, Steven [1 ]
Braun, Marie-Gabrielle [1 ]
Edgar, Kyle [1 ]
Endres, Nick [1 ]
Friedman, Lori [1 ]
Nguyen, Amanda [1 ]
Pang, Jodie [1 ]
Purkey, Hans [1 ]
Salphati, Laurent [1 ]
Schmidt, Stephen [1 ]
Song, Kyung [1 ]
Ultsch, Mark [1 ]
Jaochico, Allan [1 ]
Chan, Connie [1 ]
Eigenbrot, Charles [1 ]
MacLeod, Calum [2 ]
Jackson, Philip [2 ]
Narukulla, Raman [2 ]
Knight, Jamie [2 ]
Yeap, Kuen [2 ]
Messick, Kristen [1 ]
Valle, Nicole [1 ]
Heald, Robert [2 ]
Nannini, Michelle [1 ]
Hamilton, Pat [1 ]
Clausen, Saundra [1 ]
Young, Amy [1 ]
Sampath, Deepak [1 ]
Hong, Rebecca [1 ]
Lee, Man-Ling [1 ]
Blench, Toby [2 ]
Elliott, Richard [2 ]
Lu, Aijun [3 ]
Gu, Xiao-Hu [3 ]
Xin, Jianfeng [3 ]
机构
[1] Genentech Inc, San Francisco, CA USA
[2] Charles River Labs, Harlow, Essex, England
[3] Pharmaron, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
103
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Discovery of imidazopyridine and imidazopyridazine inhibitors of PI3K
    Han, Wooseok
    Pecchi, Sabina
    Burger, Matthew
    Lan, Jiong
    Smith, Aaron
    Knapp, Mark
    Huh, Kay
    De Menezes, Daniel Lopes
    Jansen, Johanna
    Merritt, Hanne
    Kaufman, Susan
    Voliva, Charles
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [22] Discovery and optimization of pyrimidone PI3Kβ inhibitors
    Halley, Frank
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [23] Discovery of novel pyrido[3,2-d]pyrimidine derivatives as selective and potent PI3Kδ inhibitors
    Bai, Huanrong
    Sun, Jiajia
    Lei, Hao
    Zhang, San-Qi
    Yuan, Bo
    Ma, Mengyan
    Xin, Minhang
    [J]. DRUG DEVELOPMENT RESEARCH, 2023, 84 (08) : 1709 - 1723
  • [24] Discovery of a novel and potent mutant-selective inhibitor of PI3Kα
    Gao, Mingming
    Qi, Chao
    Li, Zhentian
    Fan, Qipeng
    Wang, Liyang
    Zhou, Fei
    You, Lin
    Zheng, Hewen
    Li, Yu
    Wu, Liangxing
    Yao, Wenqing
    Liu, Phillip C.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [25] Discovery of Novel Indazoles as Potent and Selective PI3Kδ Inhibitors with High Efficacy for Treatment of Hepatocellular Carcinoma
    Qi, Jifeng
    Wang, Weihua
    Tang, Yongmei
    Lou, Shengying
    Wang, Jiaer
    Yuan, Tao
    He, Qiaojun
    Yang, Bo
    Zhu, Hong
    Cui, Sunliang
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (05) : 3849 - 3865
  • [26] Discovery of novel and highly selective PI3Kδ inhibitors based on the p110δ crystal structure
    Jia, Wen-Qing
    Liu, Ya-Ya
    Feng, Xiao-Yan
    Xu, Wei-Ren
    Cheng, Xian-Chao
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (08): : 2499 - 2508
  • [27] Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors
    Hoegenauer, Klemens
    Soldermann, Nicolas
    Stauffer, Frederic
    Furet, Pascal
    Graveleau, Nadege
    Smith, Alexander B.
    Hebach, Christina
    Hollingworth, Gregory J.
    Lewis, Ian
    Gutmann, Sascha
    Rummel, Gabriele
    Knapp, Mark
    Wolf, Romain M.
    Blanz, Joachim
    Feifel, Roland
    Burkhart, Christoph
    Zecri, Frederic
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (08): : 762 - 767
  • [28] PI3K delta: Discovery of potent and selective inhibitors for treating hematopoietic malignancies
    Mattheakis, L.
    Kearney, P.
    Jaeger, C.
    Plonowski, A.
    Zhang, J.
    Yu, P.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 72 - 72
  • [29] Discovery of potent and selective PI3Kδ inhibitors bearing amino acid fragments
    Lei, Hao
    Duan, Weiming
    Zhang, San-Qi
    Feng, Yifan
    Ma, Mengyan
    Yuan, Bo
    Xin, Minhang
    [J]. BIOORGANIC CHEMISTRY, 2023, 138
  • [30] Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kδ inhibitors
    Terstiege, Ina
    Perry, Matthew
    Petersen, Jens
    Tyrchan, Christian
    Svensson, Tor
    Lindmark, Helena
    Oster, Linda
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (03) : 679 - 687